Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
Turner
M T
MT
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D035061:Control Groups; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D038622:Internationality; D007538:Isoniazid / Q000627:therapeutic use*; D010919:Placebos; D036302:Therapeutic Human Experimentation; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014454:Uganda; D028761:Withholding Treatment
D000995:Antitubercular Agents; D010919:Placebos; D007538:Isoniazid